(Q39778366)

14 September 2017

1 reference

title

Dobutamine: a new synthetic cardioactive sympathetic amine (English)

1 reference

14 September 2017

Dobutamine: A New Synthetic Cardioactive Sympathetic Amine (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

7 April 2023

author name string

LeJemtel TH

3

1 reference

14 September 2017

E. H. Sonnenblick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A362214

7 April 2023

W. H. Frishman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A362214

7 April 2023

T. H. LeJemtel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A362214

7 April 2023

language of work or name

English

0 references

publication date

1 January 1979

1 reference

14 September 2017

4 January 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=362214

full work available at URL

7 April 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197901043000105

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

The New England Journal of Medicine

7 April 2023

published in

1 reference

14 September 2017

300

1 reference

14 September 2017

17-22

1 reference

14 September 2017

1

1 reference

Dobutamine: development of a new catecholamine to selectively increase cardiac contractility

14 September 2017

1

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

STUDIES ON THE MECHANISM OF ACTION OF METARAMINOL (ARAMINE)

7 April 2023

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Ineffectiveness of Isoproterenol in Shock Due to Acute Myocardial Infarction

7 April 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Effects of Norepinephrine on Coronary Circulation and Left Ventricular Dynamics in the Conscious Dog

7 April 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Effects and mechanisms of action of dopamine on regional hemodynamics in the conscious dog.

7 April 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Analysis of the inotropic:chronotropic selectivity of dobutamine and dopamine in anaesthetised dogs and guinea-pig isolated atria

7 April 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine

7 April 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs

7 April 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Differential adrenergic sensitivity of atrial and ventricular tissue assessed by chronotropic, inotropic, and cyclic AMP responses to isoprenaline and dobutamine

7 April 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

7 April 2023

11

1

217

Loeb

1974

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

In vivo analysis of adrenergic receptor activity of dobutamine

7 April 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Newer catecholamines for treatment of heart failure and shock: An update on dopamine and a first look at dobutamine

7 April 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

7 April 2023

15

2

29

Loeb

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Haemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure

7 April 2023

16

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Hemodynamic effect of dobutamine in patients with severe heart failure

7 April 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure

7 April 2023

18

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.

7 April 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

7 April 2023

20

3

55

Loeb

1976

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure

7 April 2023

21

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure

7 April 2023

22

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Dobutamine for Inotropic Support during Emergence from Cardiopulmonary Bypass

7 April 2023

23

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Hemodynamic effects of dobutamine in patients following open heart surgery

7 April 2023

24

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Treatment of refractory heart failure with infusion of nitroprusside.

7 April 2023

25

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

The role of vasodilator therapy in heart failure

7 April 2023

26

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure

7 April 2023

27

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure

7 April 2023

28

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Experimental Subendocardial Ischemia in Dogs with Normal Coronary Arteries

7 April 2023

29

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Mechanisms of beneficial effects of vasodilators and inotropic stimulation in the experimental failing ischemic heart

7 April 2023

30

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs

7 April 2023

32

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Effects of catecholamines, exercise, and nitroglycerin on the normal and ischemic myocardium in conscious dogs

7 April 2023

33

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

7 April 2023

Federation Proceedings

34

34

435

Vasu

1975

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs

7 April 2023

37

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

Effects of dobutamine in patients with acute myocardial infarction

7 April 2023

38

1 reference

https://api.crossref.org/works/10.1056/NEJM197901043000105

7 April 2023

Identifiers

1 reference

14 September 2017

1 reference